65,437 trials
Fibromyalgia
Primary: Change From Baseline to the Week 14 Endpoint in the Diary NRS Weekly Average of Daily Self Reported Average Pain Severity Scores. — -1.8; -1.2 score on a scale
Advanced Non-Small Cell Lung Cancer
Primary: Number of Participants With Treatment-Emergent Adverse Events (TEAEs) — 94; 89 Participants
Suicidal Ideation · Suicide, Attempted · Ptsd
Primary: Change in Suicide Ideation — 5.91; 6.37; 3.67; 2.47 units on a scale
Cardioversion · Atrial Fibrillation
Primary: Change in Quality-of-life (Atrial Fibrillation Effect on QualiTy-of-life) — 20.3; 17.9 score on a scale
Neuropsychiatric Symptoms Related to Neurodegenerative Disease
Primary: Treatment-emergent Adverse Events (TEAEs) — 238 Participants
Aplastic Anemia · Myelodysplastic Syndromes · Fungal Infection
Primary: the Incidence of Proven/Probable/Possible Fungal Infection — 20 Participants
Sleep Initiation and Maintenance Disorders
Primary: Change From Baseline of Mean Latency to Persistent Sleep (LPS) Over the Last 2 Nights of 1 Month of Treatment of Lemborexant 10 mg Compared to Placebo — -21.71; -39.47…
Locally Advanced or Metastatic Solid Tumors
Primary: Dose Escalation: Number of Participants With Dose Limiting Toxicities (DLTs) — 0; 0; 0; 2 Participants
Parenting · Child Behavior · Child Rearing
Primary: Parent - Change From Baseline Frequency of Corporal Punishment Use at 3 Months and at Long-term Follow-up — -.32; -.27; -.17; -.69 score on a scale
Stroke
Primary: All-cause Mortality During Hospitalization of Acute Ischemic Stroke (AIS) Patients — 2.6; 0.8 Percentage of participants
Sepsis · Critical Illness · Infections
Primary: 24-hour Vancomycin Area Under the Curve (AUC) From Optimally Timed Concentration — 494 mg*hr/L
Intubation Complication
Primary: Extent of Bleeding — 12; 13; 3; 3 Participants — p=1.000
Communication · Preoperative · Ethics
Primary: Number of Participants Who Recall Anesthesia Team Members — 30; 49 Participants
Type 1 Diabetes
Primary: Number of Severe Hypoglycemic Events — 0; 0 events
ER+ Breast Cancer · Breast Cancer · Aromatase Inhibitors
Primary: Blood Levels of Total Estradiol Concentration — -0.50; -0.39 Log scale, pg/mL